Back to Studies P1017 / PEG-Intron in HIV+Children Safety, Tolerability, and Antiviral Pharmacodynamics of PEG-Intron in HIV-1 Infected Children OverviewProtocol Team Study Status Concluded DAIDS Number 10317 IND Number BB9197 Primary Protocol Team Members Katherine Luzuriaga Study Chair Andrea Kovacs Study Vice-Chair Melody Higgins Clinical Research Manager Loading study documents... Loading study sites... Loading study protocol team... Loading study press... Loading study publications/presentations...